{"id":14929,"date":"2025-11-10T09:33:31","date_gmt":"2025-11-10T07:33:31","guid":{"rendered":"http:\/\/jhb-webdevelopers\/channelafrica\/news\/novo-nordisk-shares-rise-after-dropping-metsera-bid\/"},"modified":"2026-02-27T16:27:20","modified_gmt":"2026-02-27T14:27:20","slug":"novo-nordisk-shares-rise-after-dropping-metsera-bid","status":"publish","type":"news","link":"https:\/\/www.channelafrica.co.za\/channelafrica\/news\/novo-nordisk-shares-rise-after-dropping-metsera-bid\/","title":{"rendered":"Novo Nordisk shares rise after dropping Metsera bid"},"content":{"rendered":"<div><\/div>\n<div>\n<p>Novo&#8217;s shares traded 2.9% higher. US drugmaker, Pfizer said late on Friday it had clinched a $10 billion deal for Metsera, in a blow to Novo as the Danish group tries to claw back lost ground against US rival, Eli Lilly.<\/p>\n<\/div>\n<div>\n<p>&nbsp;<\/p>\n<\/div>\n<div>\n<p>Metsera accepted a sweetened offer from Pfizer late on Friday, citing US antitrust risks in Novo&#8217;s bid that it had previously called superior.<\/p>\n<p>&nbsp;<\/p>\n<p>The Danish obesity drug behemoth said on Saturday it would exit the race. The bidding war win hands Pfizer a way into the lucrative obesity drug market, even if Metsera&#8217;s treatments remain years from hitting the market.<\/p>\n<\/div>\n<div>\n<p>&nbsp;<\/p>\n<\/div>\n<div>\n<p>&#8211;Reuters&#8211;<\/p>\n<\/div>\n","protected":false},"featured_media":14930,"template":"","meta":{"_acf_changed":false},"news-type":[44],"class_list":["post-14929","news","type-news","status-publish","has-post-thumbnail","hentry","news-type-finance","entry"],"acf":{"short_description":"Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for United States (US)\u00a0weight loss drug company Metsera, ending a bidding war with rival Pfizer","published_date":"2025-11-10 00:00:00","news_description":"Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for United States (US)\u00a0weight loss drug company Metsera, ending a bidding war with rival Pfizer","form_embed":"","author":"","image_caption":""},"_links":{"self":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/14929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":1,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/14929\/revisions"}],"predecessor-version":[{"id":19379,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news\/14929\/revisions\/19379"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media\/14930"}],"wp:attachment":[{"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/media?parent=14929"}],"wp:term":[{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.channelafrica.co.za\/channelafrica\/wp-json\/wp\/v2\/news-type?post=14929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}